Salivary 17 alpha - hydroxyprogesterone in management of congenital adrenal hyperplasia (1991)
Fonte: Journal of Pediatric Endocrinology. Unidades: FMRP, FFCLRP
Assunto: QUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, H H A et al. Salivary 17 alpha - hydroxyprogesterone in management of congenital adrenal hyperplasia. Journal of Pediatric Endocrinology, v. 4, p. 255-262, 1991Tradução . . Acesso em: 12 nov. 2024.APA
Oliveira, H. H. A., Moreira, A. C., Rossi, A., & Cruz, C. (1991). Salivary 17 alpha - hydroxyprogesterone in management of congenital adrenal hyperplasia. Journal of Pediatric Endocrinology, 4, 255-262.NLM
Oliveira HHA, Moreira AC, Rossi A, Cruz C. Salivary 17 alpha - hydroxyprogesterone in management of congenital adrenal hyperplasia. Journal of Pediatric Endocrinology. 1991 ; 4 255-262.[citado 2024 nov. 12 ]Vancouver
Oliveira HHA, Moreira AC, Rossi A, Cruz C. Salivary 17 alpha - hydroxyprogesterone in management of congenital adrenal hyperplasia. Journal of Pediatric Endocrinology. 1991 ; 4 255-262.[citado 2024 nov. 12 ]
